Brief: Cabaletta Bio Appoints Samik Basu As Chief Scientific Officer
09/11/2021 13:13
Nov 9 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO EXPANDS EXECUTIVE LEADERSHIP TEAM WITH
APPOINTMENTS OF SAMIK BASU, M.D. TO CHIEF SCIENTIFIC OFFICER AND
HEATHER HARTE-HALL, MSC. TO CHIEF COMPLIANCE OFFICER
Source text for Eikon: ID:nGNX8lzNn4
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity